Glycopyrrolate 0.0156 MG Inhalant Powder [Seebri]

Known as: Seebri 0.0156 MG Inhalant Powder, GLYCOPYRROLATE 15.6 ug RESPIRATORY (INHALATION) CAPSULE [SEEBRI NEOHALER], seebri neohaler 15.6 MCG Inhalant Powder Capsule 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2017
01220122017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
  • The Medical letter on drugs and therapeutics
  • 2016
 
Is this relevant?
2015
2015
OBJECTIVES The objective of this study was to compare the cost effectiveness of once-daily Seebri Breezhaler(®) (glycopyrronium… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2015
Review
2015
INTRODUCTION Long-acting bronchodilators are the mainstay of pharmacological therapy for patients with chronic obstructive… (More)
Is this relevant?
2012
2012
  • Seebri Breezhaler
  • 2012
 
  • table 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?